| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000027524 |
| Receipt No. | R000031491 |
| Official scientific title of the study | Research about the onset mechanism of the gastric cancer after the antimicrobial treatment for Helicobacter pylori. |
| Date of disclosure of the study information | 2017/06/01 |
| Last modified on | 2017/05/29 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Research about the onset mechanism of the gastric cancer after the antimicrobial treatment for Helicobacter pylori. | |
| Title of the study (Brief title) | Research about the onset mechanism of the gastric cancer after the antimicrobial treatment. | |
| Region |
|
|
| Condition | |||
| Condition | Gstric cancer and chronic gastritis after the Helicobacter pylori antimicrobial treatment | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | It is intended to search the gene expression causing the map-like redness and a background gastric mucosa associated with the second cancer outbreak after the Helicobacter pylori antimicrobial treatment. |
| Basic objectives2 | Others |
| Basic objectives -Others | We try to perform a genome-wide search using miRNA derived from exosome and to identify new biomarkers associated with the second cancer outbreak after the Helicobacter pylori antimicrobial treatment by analyzing gene expression by microarray. |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | The gene expression causing the map-like redness and a background gastric mucosa associated with the second cancer outbreak after the Helicobacter pylori antimicrobial treatment. |
| Key secondary outcomes | New biomarkers associated with the second cancer outbreak after the Helicobacter pylori antimicrobial treatment. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients whom gastric cancer developed in after antimicrobial treatment for Helicobacter pylori and control group after antimicrobial treatment that matched the number of years,sex,age. | |||
| Key exclusion criteria | Exclusion criteria are history of gastrectomy, and patients with gastric cancer or other malignant lesions, pylori-positive,hemorrhagic diseases, cirrhosis or renal failure. | |||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Kyosuke Goda |
| Organization | Kawasaki Medical School |
| Division name | Division of Gastroenterology Department of Internal Medicine |
| Address | 577 Matsushima Kurashiki City Okayama Prefecture 701-0192 Japan |
| TEL | 086-462-1111 |
| gooooo_ddy@yahoo.co.jp | |
| Public contact | |
| Name of contact person | Kyosuke Goda |
| Organization | Kawasaki Medical School |
| Division name | Division of Gastroenterology Department of Internal Medicine |
| Address | 577 Matsushima Kurashiki City Okayama Prefecture 701-0192 Japan |
| TEL | 086-462-1111 |
| Homepage URL | |
| gooooo_ddy@yahoo.co.jp | |
| Sponsor | |
| Institute | Kawasaki Medical School |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kawasaki Medical School |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | The study will be approved by the Ethical Committee of Kawasaki Medical School. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031491 |